查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197282

充氣設備市場 - 增長、趨勢和預測 (2023-2028)

Inflation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，充氣設備市場預計將以 4.7% 的複合年增長率增長。

COVID-19 正在以多種方式影響對醫療設備的需求。 重症監護室對用於治療 COVID-19 患者的設備的需求有所增加，而其他設備則因治療延誤和取消而陷入困境。 但是，很少有感染 COVID-19 的人患心血管疾病的風險增加的例子。 2022 年 2 月發表在《自然醫學》上的一項研究發現，急性 COVID-19 的倖存者患心血管疾病的風險更大，一年的負擔也更大。 因此，血管成形術必須用於治療心血管疾病，例如需要充氣裝置的冠狀動脈疾病。 因此，市場有望在後 COVID-19 時期和未來幾年產生積極影響。

受老齡化人群泌尿和心血管疾病發病率上升、發達地區微創手術需求增加、微創手術報銷等因素影響，充氣器械市場正在增長。我來了。

主要亮點

  • 根據世衛組織發布的《2022 年老齡化與健康事實》，全球 60 歲及以上人口將在 2015 年至 2050 年間從 12% 增加到 22%。 到 2050 年，大約 80% 的老年人將生活在低收入和中等收入國家。 衰老是影響心血管和泌尿系統疾病的重要因素。 因此，隨著人口老齡化的加劇，對這些疾病的血管成形術等管理設備的需求將增加。 此外，根據歐洲心臟網絡2021公佈的數據，歐盟有超過6000萬人患有心血管疾病。 每年新增確診病例超過1300萬例。 因此，心血管疾病發病率的增加和老年人口的增加將增加疾病管理方法，推動預測期內市場的增長。
  • 但是，與手術相關的高成本和並發症（例如感染和出血風險）預計會阻礙市場增長。

充氣設備市場趨勢

模擬顯示的充氣設備領域預計將佔據很大的市場份額

模擬顯示充氣儀用於在血管成形術過程中為球囊充氣/放氣，並具有精確的模擬式壓力控制計。 模擬顯示充氣設備部分預計將在充氣設備市場佔有更大的份額。 該細分市場的絕對高收入份額是由於模擬充氣設備的低成本和便攜性。 由於與數字充氣設備相比成本較低，越來越多的患者採用模擬充氣設備，也推動了市場的增長。

除了模擬顯示器的優勢外，心血管疾病患病率上升、老年人口增加以及對微創手術的偏好上升等其他驅動因素正在刺激對該細分市場的需求並推動市場向前發展。預計這將是有用的 根據澳大利亞健康與福利研究所 2022 年澳大利亞統計局 2020-21 NHS 自我報告的數據，估計 18 歲及以上的澳大利亞人（佔成年人口的 2.9%）在 2020-2021 年患有慢性心髒病它一直。 此外，該地區冠狀動脈疾病的高患病率導致更多的心臟介入手術，預計這將支持本研究的市場增長。

模擬顯示充氣設備是介入氣球充氣的黃金標準。 大多數繁忙的介入實驗室可以依靠模擬顯示充氣設備來執行他們的程序。 因此，在預測期內，慢性心髒病的益處和患病率上升預計將在研究市場中佔有重要的市場份額。

預計在預測期內北美將佔據很大的市場份額

預計北美將在充氣設備市場中佔據很大份額。 這是由於需要介入手術的疾病高發、微創技術知識的增加以及該地區微創設備的使用越來越多。 例如，根據 CDC 2022，美國四分之一的死亡是由於心髒病，每年影響約 659,000 人，導致對血管成形術的需求增加。 這推動了該地區的充氣設備市場。

同樣，根據加拿大心臟和中風基金會發布的數據，到 2022 年 2 月，加拿大將有 75 萬名心力衰竭患者，每年將報告 10 萬例這種致命疾病的新病例。我在這裡。 因此，血管成形術等最小限度的手術干預有助於排除心血管風險。 因此，心髒病的顯著流行可以推動該地區的市場。

此外，市場上的主要參與者正在共同開發支持市場增長的血管通路產品。 例如，2022 年 8 月，Teleflex, Inc. 贏得了美國最大的會員制醫療績效改善公司 Vizient, Inc. 的中央靜脈通路產品供應合同。 這些合同幫助公司通過血管成形術等外科手術進入血管，並使市場在預測期內增長。

因此，由於上述因素，預計北美將佔據很大的市場份額。

充氣設備市場競爭對手分析

充氣設備市場競爭激烈，由多家大型企業組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 一些主要參與者正在積極收購其他公司以鞏固其在全球的市場地位，而另一些則正在分銷其產品。 主要參與者包括 Johnson & Johnson Service Inc.、Merit Medical Systems、Argon Medical、B.Brown SE、Teleflex、Terumo Medical、ConMed、Medtronic、BD、Boston Scientific Corporation 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 老年人泌尿系統和心血管疾病的發病率增加
    • 發達國家對微創手術的需求增加，醫療報銷增加
  • 市場製約因素
    • 手術費用高
    • 手術相關並發症，例如感染和出血風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按顯示類型
    • 模擬顯示
    • 數字顯示
  • 通過申請
    • 介入心髒病學
    • 介入放射學
    • 外周血管治療
    • 消化外科
    • 泌尿外科領域
    • 其他應用
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 其他最終用戶
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Johnson & Johnson Services Inc.
    • Merit Medical Systems
    • ARGON MEDICAL
    • B. Braun SE
    • Teleflex Incorporated
    • Terumo Medical Corporation
    • CONMED Corporation
    • Medtronic
    • BD（Becton, Dickinson and Company）
    • Boston Scientific Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 67476

The inflation devices market is expected to register a CAGR of 4.7% over the forecast period.

In many ways, COVID-19 has influenced the demand for medical equipment. While there was an increase in demand for the devices used to treat COVID-19 patients in intensive care, other devices suffered due to postponed or canceled treatments. However, there are few instances of individuals infected with COVID-19 being at increased risk of cardiovascular disease. According to the study report published by Nature Medicine in February 2022, in survivors with acute COVID-19, there is a significant risk of cardiovascular disease and a one-year burden. Hence to manage cardiovascular diseases like coronary artery disease, angioplasty should be used, which needs inflation devices. Thus the market is expected to have a positive impact during the post-COVID-19 period and in the coming years.

The inflation devices market is growing due to certain factors, such as the increased incidences of urological diseases and cardiovascular diseases in the geriatric population and a rise in the demand for minimally invasive procedures and medical reimbursement for minimally invasive procedures in developed regions.

Key Highlights

  • According to the WHO facts of aging and health 2022, people over 60 years in the world will increase from 12% to 22% between 2015 and 2050. About 80% of senior citizens will reside in low- and middle-income nations by 2050. Aging is a critical factor that influences cardiovascular and urological diseases. Hence, the demand for management devices like angioplasty for those diseases increases with the growing aging population. Furthermore, according to the data published by the European Heart network 2021, more than 60 million people in the European Union have cardiovascular illnesses. Every year, over 13 million new cases are identified. Thus, the increased incidences of cardiovascular diseases and the senior population increase the disease management methods and drive the market's growth over the forecast period.
  • However, the high cost and complications associated with procedures, such as the risk of infection and bleeding, are expected to hamper the market growth.

Inflation Devices Market Trends

Analog Display Inflation Devices Segment is Expected to Hold a Significant Share in the Market

An analog display inflation device is used to inflate/ deflate a balloon during the angioplasty procedure and has a precise analog-type pressure control gauge. The analog display inflation devices segment is expected to account for a more significant share of the inflation devices market. This segment's dominance in this segment's revenue share is due to the low cost and portability of analog inflation devices. Also, an increase in the adoption of analog inflation devices by patients compared to that of digital inflation devices due to less cost fuel the market's growth.

Along with the advantages of the analog display, the other driving factors, like the growing prevalence of cardiovascular diseases, the rising geriatric population, and the rising preference for minimally invasive surgeries, are expected to fuel the demand for the segment and help propel the market. According to the Australian Institute of Health and Welfare 2022, based on self-reported data from the Australian Bureau of Statistics 2020-21 NHS, an estimated 571,000 Australians aged 18 and over (2.9% of the adult population) had chronic cardiac illnesses in 2020-2021. Additionally, more cardiology intervention operations are being performed due to the high prevalence of coronary artery disease in the area, which is anticipated to support market growth in the study.

An analog display inflation device is a gold standard for interventional balloon inflation. Most busy interventional labs can rely on the analog display inflation device for their procedures. Hence the advantages and rising prevalence of chronic heart diseases are expected to occupy a significant market share in the studied market over the forecast period.

North America is Expected to have a Significant Share in the Market over the Forecast Period

North America is anticipated to account for a significant share of the inflation devices market. The high prevalence of disorders needing interventional procedures, increased knowledge of minimally invasive techniques, and expanding use of minimally invasive devices in the area are all contributing factors. For instance, according to CDC 2022, one in every four deaths in the United States is caused by heart disease, which affects roughly 659,000 people annually, resulting in higher demand for angioplasty procedures. This drives the inflation devices market in the region.

Similarly, per the data published by the Heart and Stroke Foundation of Canada, in February 2022, 750,000 heart failure sufferers in Canada and 100,000 new cases of this fatal disease are reported each year. Hence minimal surgical interventions like angioplasty can help rule out a cardiovascular risk. Thus the significant prevalence of heart diseases can drive the market in the region.

Furthermore, the major players in the market are collaborating to develop vascular access products that help the market grow. For instance, in August 2022, Teleflex Incorporated was awarded a contract to supply Central Venous Access products from Vizient, Inc., the nation's largest member-driven healthcare performance improvement company. These contracts can help the companies to access the blood vessels through surgical interventions like angioplasty and allow the market to grow over the forecast period.

Therefore, owing to the abovementioned factors, North America is expected to hold a significant market share.

Inflation Devices Market Competitor Analysis

The inflation devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously acquiring other companies to consolidate their market positions across the globe and while others are distributing products. Some of the major players in the market are Johnson & Johnson Services Inc., Merit Medical Systems, ARGON MEDICAL, B. Braun SE, Teleflex Incorporated, Terumo Medical Corporation, CONMED Corporation, Medtronic, BD, and Boston Scientific Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Incidences of Urological Diseases and Cardiovascular Diseases in Geriatric Population
    • 4.2.2 Rise in the Demand for Minimal Invasive Procedures and Medical Reimbursements in Developed Regions
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedures
    • 4.3.2 Complications Associated in Procedures such as Risk of Infection and Bleeding
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Display Type
    • 5.1.1 Analog Display
    • 5.1.2 Digital Display
  • 5.2 By Application
    • 5.2.1 Interventional Cardiology
    • 5.2.2 Interventional Radiology
    • 5.2.3 Peripheral Vascular Procedures
    • 5.2.4 Gastroenterology Procedures
    • 5.2.5 Urology Procedures
    • 5.2.6 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Center
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson & Johnson Services Inc.
    • 6.1.2 Merit Medical Systems
    • 6.1.3 ARGON MEDICAL
    • 6.1.4 B. Braun SE
    • 6.1.5 Teleflex Incorporated
    • 6.1.6 Terumo Medical Corporation
    • 6.1.7 CONMED Corporation
    • 6.1.8 Medtronic
    • 6.1.9 BD (Becton, Dickinson and Company)
    • 6.1.10 Boston Scientific Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS